Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NACAP1 |
| Upstream (Parents) |
|---|
| (<<) LY6E → NACAP1 |
| (<<) ATXN7L1 → NACAP1 |
| (<<) METRN → NACAP1 |
| (<<) FDXR → NACAP1 |
| (<<) RPL27 → NACAP1 |
| (<<) CDC37L1 → NACAP1 |
| (<<) ALMS1 → NACAP1 |
| Downstream (Children) |
|---|
| NACAP1 → RARS2 (>>) |
| NACAP1 → DOCK5 (>>) |
| NACAP1 → LOC440366 (>>) |
| NACAP1 → SH3GL3 (>>) |
| NACAP1 → TIMM8A (>>) |
| NACAP1 → THAP3 (>>) |
| NACAP1 → ZNF550 (>>) |
| NACAP1 → MSI1 (>>) |
| NACAP1 → ATRIP///TREX1 (>>) |
| NACAP1 → RGS3 (>>) |
| NACAP1 → ANK3 (>>) |
| NACAP1 → ALPPL2///ALPP (>>) |
| NACAP1 → GTPBP1 (>>) |
| NACAP1 → POLR2L (>>) |
| NACAP1 → FOLR3 (>>) |
| NACAP1 → LAT2 (>>) |
| NACAP1 → ATXN7L1 (>>) |
| NACAP1 → LOC100133005///RASA4P///RASA4 (>>) |
| NACAP1 → TBC1D13 (>>) |
| NACAP1 → KCTD2 (>>) |
| NACAP1 → METRN (>>) |
| NACAP1 → ECE2 (>>) |
| NACAP1 → ALPK1 (>>) |
| NACAP1 → KIAA0427 (>>) |
| NACAP1 → C20orf117 (>>) |
| NACAP1 → RPL27 (>>) |
| NACAP1 → AMDHD2 (>>) |
| NACAP1 → PGLYRP4 (>>) |
| NACAP1 → ALMS1 (>>) |
| NACAP1 → ADAMTS9 (>>) |
